Abbott's Simcor gains approval
Libertyville Township-based Abbott received U.S. Food and Drug Administration approval for two new dosage strengths of Simcor, a cholesterol medication.
The new dosage strengths combine 40 mg of simvastatin - the most commonly prescribed dose of simvastatin - with either 500 mg or 1,000 mg of niacin extended-release.
Simcor is the first treatment to combine Abbott's proprietary niacin extended-release and simvastatin, the most commonly used statin.
Article Comments
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked.
If a comment violates these standards or our terms of service, click the "flag" link in the lower-right corner of the comment box. To find our more, read our FAQ.